HomeCompareHLTRF vs VICI

HLTRF vs VICI: Dividend Comparison 2026

HLTRF yields 66.67% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $955.3K in total portfolio value· pulled ahead in Year 5
10 years
HLTRF
HLTRF
● Live price
66.67%
Share price
$3.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.5K
Annual income
$11.08
Full HLTRF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — HLTRF vs VICI

📍 VICI pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLTRFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLTRF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLTRF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLTRF
Annual income on $10K today (after 15% tax)
$5,666.67/yr
After 10yr DRIP, annual income (after tax)
$9.42/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, VICI beats the other by $529,762.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLTRF + VICI for your $10,000?

HLTRF: 50%VICI: 50%
100% VICI50/50100% HLTRF
Portfolio after 10yr
$511.1K
Annual income
$311,636.20/yr
Blended yield
60.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

HLTRF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-1.0
Piotroski
5/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLTRF buys
0
VICI buys
0
No recent congressional trades found for HLTRF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLTRFVICI
Forward yield66.67%6.57%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%44.3%
Portfolio after 10y$33.5K$988.8K
Annual income after 10y$11.08$623,261.32
Total dividends collected$8.1K$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: HLTRF vs VICI ($10,000, DRIP)

YearHLTRF PortfolioHLTRF Income/yrVICI PortfolioVICI Income/yrGap
1$14,033$3,333.33$11,368$948.43+$2.7KHLTRF
2$17,202$2,185.88$13,339$1,493.16+$3.9KHLTRF
3$19,658$1,252.04$16,326$2,426.21+$3.3KHLTRF
4$21,702$668.61$21,123$4,112.15+$579.00HLTRF
5← crossover$23,566$344.93$29,379$7,368.23$5.8KVICI
6$25,391$175.03$44,804$14,191.64$19.4KVICI
7$27,257$88.12$76,658$29,972.12$49.4KVICI
8$29,209$44.20$150,894$71,015.81$121.7KVICI
9$31,276$22.14$350,814$193,582.47$319.5KVICI
10$33,476$11.08$988,809$623,261.32$955.3KVICI

HLTRF vs VICI: Complete Analysis 2026

HLTRFStock

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; Canadian rights of Trinomia for CV therapeutics; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada.

Full HLTRF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this HLTRF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLTRF vs SCHDHLTRF vs JEPIHLTRF vs OHLTRF vs KOHLTRF vs MAINHLTRF vs NNNHLTRF vs EPRTHLTRF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.